The findings presented herein suggest that the interplay between anti-diabetic drug metformin, its derivatives and cholinesterase inhibitors may be complex and need to be further examined to rationalise their beneficial effects on the symptomatic treatment of AD. The gene discussed is BCHE; the disease is Alzheimer disease.